1. Home
  2. ABVX vs EMD Comparison

ABVX vs EMD Comparison

Compare ABVX & EMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • EMD
  • Stock Information
  • Founded
  • ABVX 2013
  • EMD 2003
  • Country
  • ABVX France
  • EMD United States
  • Employees
  • ABVX N/A
  • EMD N/A
  • Industry
  • ABVX
  • EMD Finance/Investors Services
  • Sector
  • ABVX
  • EMD Finance
  • Exchange
  • ABVX Nasdaq
  • EMD Nasdaq
  • Market Cap
  • ABVX 722.3M
  • EMD 587.9M
  • IPO Year
  • ABVX N/A
  • EMD N/A
  • Fundamental
  • Price
  • ABVX $8.08
  • EMD $9.83
  • Analyst Decision
  • ABVX Strong Buy
  • EMD
  • Analyst Count
  • ABVX 7
  • EMD 0
  • Target Price
  • ABVX $37.86
  • EMD N/A
  • AVG Volume (30 Days)
  • ABVX 162.8K
  • EMD 248.5K
  • Earning Date
  • ABVX 03-24-2025
  • EMD 01-01-0001
  • Dividend Yield
  • ABVX N/A
  • EMD 10.25%
  • EPS Growth
  • ABVX N/A
  • EMD N/A
  • EPS
  • ABVX N/A
  • EMD N/A
  • Revenue
  • ABVX $9,676,417.00
  • EMD N/A
  • Revenue This Year
  • ABVX $31.67
  • EMD N/A
  • Revenue Next Year
  • ABVX $759.77
  • EMD N/A
  • P/E Ratio
  • ABVX N/A
  • EMD N/A
  • Revenue Growth
  • ABVX 100.87
  • EMD N/A
  • 52 Week Low
  • ABVX $5.50
  • EMD $7.85
  • 52 Week High
  • ABVX $17.02
  • EMD $9.55
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 75.42
  • EMD 44.36
  • Support Level
  • ABVX $5.88
  • EMD $9.88
  • Resistance Level
  • ABVX $7.57
  • EMD $10.05
  • Average True Range (ATR)
  • ABVX 0.46
  • EMD 0.11
  • MACD
  • ABVX 0.24
  • EMD -0.01
  • Stochastic Oscillator
  • ABVX 97.68
  • EMD 24.24

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.

About EMD Western Asset Emerging Markets Debt Fund Inc

Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management investment company. Its primary investment objective is to seek high current income and the secondary objective is to seek capital appreciation.

Share on Social Networks: